Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sagimet Biosciences Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 587K | May 6, 2024 | Direct | ||
Provention Bio, Inc. | Chief Financial Officer | Option to Purchase Common Stock | 0 | Apr 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMT | Sagimet Biosciences Inc. | May 6, 2024 | 1 | $0 | 4 | May 8, 2024 | Chief Financial Officer |
SGMT | Sagimet Biosciences Inc. | May 6, 2024 | 0 | $0 | 3 | May 8, 2024 | Chief Financial Officer |
PRVB | Provention Bio, Inc. | Apr 27, 2023 | 3 | $0 | 4 | Apr 27, 2023 | Chief Financial Officer |
PRVB | Provention Bio, Inc. | Jan 10, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Chief Financial Officer |
PRVB | Provention Bio, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Financial Officer |
PRVB | Provention Bio, Inc. | Dec 1, 2021 | 1 | $0 | 4 | Dec 1, 2021 | Chief Financial Officer |
PRVB | Provention Bio, Inc. | Dec 1, 2021 | 0 | $0 | 3 | Dec 1, 2021 | Chief Financial Officer |